Serum leucine‐rich alpha‐2 glycoprotein in monitoring disease activity and intestinal mucosal healing for biotherapy‐naïve cases with ulcerative colitis

Abstract Background and Aim Serum leucine‐rich alpha‐2 glycoprotein level has been reported to be a useful biomarker in assessing mucosal healing in patients undergoing biotherapy, where mucosal lesions caused by ulcerative colitis are difficult to assess endoscopically. However, no such reports hav...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Masashi Kono, Yoriaki Komeda, George Tribonias, Saki Yoshida, Kenji Nomura, Kohei Handa, Tomoyuki Nagai, Satoru Hagiwara, Shunsuke Omoto, Mamoru Takenaka, Naoshi Nishida, Naoko Tsuji, Hiroshi Kashida, Masatoshi Kudo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2023-08-01
Saila:	JGH Open
Gaiak:	biotherapy‐naïve leucine‐rich alpha‐2 glycoprotein ulcerative colitis
Sarrera elektronikoa:	https://doi.org/10.1002/jgh3.12953
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!